Atherogenic Dyslipidemia
Approach to identifying and managing atherogenic dyslipidemia
12
The Atherogenic Dyslipidemia Ratio Log (Tg)/Hdl C Was Not Associated with Urinary Albumin Excretion Rate (Uaer) and Increased Cardiovascular Risk in Black Patients with Type 2 Diabetes
7
Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
11
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
8
Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
10
Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
5
Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss
5
Abnormal High-Density Lipoproteins in Overweight Adolescents With Atherogenic Dyslipidemia
9
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
10
Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population
7
The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females
8
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
7
NOVEL BIOMARKERS OF ATHEROGENIC DIET INDUCED DYSLIPIDEMIA AND METABOLIC SYNDROME SUPPRESSED BY TERMINALIA ARJUNA
9
Dyslipidemia in women: etiology and management
10
Treating Dyslipidemia in Adults: An Update
22
Evaluation of the Effect of Biotin in Dyslipidemia
129
EXPLORING THE POTENTIAL EFFECTS OF AMARANTHUS TRICOLOR LEAVES IN DYSLIPIDEMIA AND DYSLIPIDEMIA INDUCED COMPLICATIONS IN RATS
9
Pattern of Dyslipidemia in Diabetes Mellitus
6
An Update on Pharmacotherapy of Dyslipidemia for Adults
24
Dyslipidemia in Treatment Naïve HIV
132